http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102964405-B
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate | 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102964405-B |
titleOfInvention | A kind of application with the Vaccarin promoting angiogenesis |
abstract | A kind of application with the Vaccarin promoting angiogenesis, belongs to application in TCM technical field.Present invention firstly discovers that Vaccarin has the activity promoting angiogenesis, the ischemic heart desease such as can be used for after coronary heart disease, scheming infarction, after cerebral infarction, occlusive thromboangiitis, cardiovascular accesses art, suppresses prevention and the treatment of the disease of the associated angiogenesis such as spot formation in wound healing.This Vaccarin can be applicable to the purposes such as pharmaceutical preparation, nutriment, health product, cosmetics. |
priorityDate | 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.